Stoneridge Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$8.54M |
| 2 |
Chubb
CB
|
+$7.86M |
| 3 |
Citigroup
C
|
+$6.58M |
| 4 |
Fidelity National Information Services
FIS
|
+$5.57M |
| 5 |
American International
AIG
|
+$4.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$11M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$7.56M |
| 3 |
WEC Energy
WEC
|
+$5.59M |
| 4 |
L3Harris
LHX
|
+$4.44M |
| 5 |
Zimmer Biomet
ZBH
|
+$3.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.56% |
| 2 | Financials | 11.47% |
| 3 | Industrials | 9.71% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Communication Services | 9.31% |
Similar funds
Stoneridge Investment Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Stoneridge Investment Partners held 168 positions worth $280M, up 4% from $269M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Stoneridge Investment Partners deployed $9.98M of net new capital in Q4 2024, opening 48 new positions and adding to 41 existing holdings. Its largest new stake was Chubb: 27,680 shares worth $7.65M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was General Motors, an estimated $3.69M trimmed.
- Stoneridge Investment Partners's largest Q4 2024 buy was Chubb: 27,680 shares worth $7.65M.
- Stoneridge Investment Partners added most to CVS Health in Q4 2024, an estimated $8.54M increase.
- Stoneridge Investment Partners's biggest Q4 2024 reduction was General Motors, cutting an estimated $3.69M.
- Stoneridge Investment Partners fully exited Wells Fargo in Q4 2024, selling an estimated $11M.
- Stoneridge Investment Partners's ten largest holdings make up 39% of its $280M portfolio in Q4 2024.
- Stoneridge Investment Partners opened 48 new positions and closed 33 in Q4 2024.
- Stoneridge Investment Partners's portfolio value rose 4% quarter-over-quarter to $280M.
Based on Stoneridge Investment Partners's 13F filing for Q4 2024, filed 28 Jan 2025.